Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides

Hiromichi Akizawa, Yasushi Arano, Masaki Mifune, Akimasa Iwado, Yutaka Saito, Tomoya Uehara, Masahiro Ono, Yasushi Fujioka, Kazuma Ogawa, Yoshiaki Kiso, Hideo Saji

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Metabolic studies of 111In-DTPA-labeled polypeptides and peptides showed that the radiolabeled (poly)peptides generated 111In-DTPA-adducts of amino acid that possess long residence times in the lysosomal compartment of the tissues where (poly)peptides accumulated. However, a recent study suggested that metal-chelate-methionine (Met) might possess in vivo behaviors different from metal-chelate adducts of other amino acids. In this study, to elucidate whether some biological characteristics of Met may accelerate the renal elimination rate of 111In-DTPA-adduct of Met into urine, 111In-DTPA-Met1-octreotide was synthesized and the renal handling of 111In-DTPA-Met was investigated using 111In-DTPA-L-Phe1-octreotide (Phe represents phenylalanine), which was reported previously, as a reference. Both 111In-DTPA-conjugated octreotide analogs were stable against 3-h incubation in murine serum at 37°C. Both 111In-DTPA-octreotide analogs also showed rapid clearance of the radioactivity from the blood and similar accumulation of the radioactivity in the kidney. No significant differences were observed in the renal radioactivity levels from 10 min to 24 h postinjection between the two. Metabolic studies indicated that 111In-DTPA-Met1-octreotide and 111In-DTPA-L-Phe1-octreotide generated 111In-DTPA-adducts of Met and Phe, respectively, as the final radiometabolites at similar rates. These findings suggested that the long residence times of the radioactivity in tissues after administration of 111In-DTPA-labeled peptides and polypeptides would be attributed to inherent characteristics of 111In-DTPA chelate.

Original languageEnglish
Pages (from-to)459-468
Number of pages10
JournalNuclear Medicine and Biology
Volume28
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Pentetic Acid
Radioactivity
Kidney
Peptides
Methionine
Octreotide
Metals
Amino Acids
Phenylalanine

Keywords

  • In-DTPA chelate
  • In-DTPA-amino acid
  • In-DTPA-peptide
  • Renal radioactivity level

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides. / Akizawa, Hiromichi; Arano, Yasushi; Mifune, Masaki; Iwado, Akimasa; Saito, Yutaka; Uehara, Tomoya; Ono, Masahiro; Fujioka, Yasushi; Ogawa, Kazuma; Kiso, Yoshiaki; Saji, Hideo.

In: Nuclear Medicine and Biology, Vol. 28, No. 4, 2001, p. 459-468.

Research output: Contribution to journalArticle

Akizawa, H, Arano, Y, Mifune, M, Iwado, A, Saito, Y, Uehara, T, Ono, M, Fujioka, Y, Ogawa, K, Kiso, Y & Saji, H 2001, 'Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides', Nuclear Medicine and Biology, vol. 28, no. 4, pp. 459-468. https://doi.org/10.1016/S0969-8051(01)00207-4
Akizawa, Hiromichi ; Arano, Yasushi ; Mifune, Masaki ; Iwado, Akimasa ; Saito, Yutaka ; Uehara, Tomoya ; Ono, Masahiro ; Fujioka, Yasushi ; Ogawa, Kazuma ; Kiso, Yoshiaki ; Saji, Hideo. / Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides. In: Nuclear Medicine and Biology. 2001 ; Vol. 28, No. 4. pp. 459-468.
@article{cf469ef4f6e9417692b9b4ac8054b76d,
title = "Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides",
abstract = "Metabolic studies of 111In-DTPA-labeled polypeptides and peptides showed that the radiolabeled (poly)peptides generated 111In-DTPA-adducts of amino acid that possess long residence times in the lysosomal compartment of the tissues where (poly)peptides accumulated. However, a recent study suggested that metal-chelate-methionine (Met) might possess in vivo behaviors different from metal-chelate adducts of other amino acids. In this study, to elucidate whether some biological characteristics of Met may accelerate the renal elimination rate of 111In-DTPA-adduct of Met into urine, 111In-DTPA-Met1-octreotide was synthesized and the renal handling of 111In-DTPA-Met was investigated using 111In-DTPA-L-Phe1-octreotide (Phe represents phenylalanine), which was reported previously, as a reference. Both 111In-DTPA-conjugated octreotide analogs were stable against 3-h incubation in murine serum at 37°C. Both 111In-DTPA-octreotide analogs also showed rapid clearance of the radioactivity from the blood and similar accumulation of the radioactivity in the kidney. No significant differences were observed in the renal radioactivity levels from 10 min to 24 h postinjection between the two. Metabolic studies indicated that 111In-DTPA-Met1-octreotide and 111In-DTPA-L-Phe1-octreotide generated 111In-DTPA-adducts of Met and Phe, respectively, as the final radiometabolites at similar rates. These findings suggested that the long residence times of the radioactivity in tissues after administration of 111In-DTPA-labeled peptides and polypeptides would be attributed to inherent characteristics of 111In-DTPA chelate.",
keywords = "In-DTPA chelate, In-DTPA-amino acid, In-DTPA-peptide, Renal radioactivity level",
author = "Hiromichi Akizawa and Yasushi Arano and Masaki Mifune and Akimasa Iwado and Yutaka Saito and Tomoya Uehara and Masahiro Ono and Yasushi Fujioka and Kazuma Ogawa and Yoshiaki Kiso and Hideo Saji",
year = "2001",
doi = "10.1016/S0969-8051(01)00207-4",
language = "English",
volume = "28",
pages = "459--468",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides

AU - Akizawa, Hiromichi

AU - Arano, Yasushi

AU - Mifune, Masaki

AU - Iwado, Akimasa

AU - Saito, Yutaka

AU - Uehara, Tomoya

AU - Ono, Masahiro

AU - Fujioka, Yasushi

AU - Ogawa, Kazuma

AU - Kiso, Yoshiaki

AU - Saji, Hideo

PY - 2001

Y1 - 2001

N2 - Metabolic studies of 111In-DTPA-labeled polypeptides and peptides showed that the radiolabeled (poly)peptides generated 111In-DTPA-adducts of amino acid that possess long residence times in the lysosomal compartment of the tissues where (poly)peptides accumulated. However, a recent study suggested that metal-chelate-methionine (Met) might possess in vivo behaviors different from metal-chelate adducts of other amino acids. In this study, to elucidate whether some biological characteristics of Met may accelerate the renal elimination rate of 111In-DTPA-adduct of Met into urine, 111In-DTPA-Met1-octreotide was synthesized and the renal handling of 111In-DTPA-Met was investigated using 111In-DTPA-L-Phe1-octreotide (Phe represents phenylalanine), which was reported previously, as a reference. Both 111In-DTPA-conjugated octreotide analogs were stable against 3-h incubation in murine serum at 37°C. Both 111In-DTPA-octreotide analogs also showed rapid clearance of the radioactivity from the blood and similar accumulation of the radioactivity in the kidney. No significant differences were observed in the renal radioactivity levels from 10 min to 24 h postinjection between the two. Metabolic studies indicated that 111In-DTPA-Met1-octreotide and 111In-DTPA-L-Phe1-octreotide generated 111In-DTPA-adducts of Met and Phe, respectively, as the final radiometabolites at similar rates. These findings suggested that the long residence times of the radioactivity in tissues after administration of 111In-DTPA-labeled peptides and polypeptides would be attributed to inherent characteristics of 111In-DTPA chelate.

AB - Metabolic studies of 111In-DTPA-labeled polypeptides and peptides showed that the radiolabeled (poly)peptides generated 111In-DTPA-adducts of amino acid that possess long residence times in the lysosomal compartment of the tissues where (poly)peptides accumulated. However, a recent study suggested that metal-chelate-methionine (Met) might possess in vivo behaviors different from metal-chelate adducts of other amino acids. In this study, to elucidate whether some biological characteristics of Met may accelerate the renal elimination rate of 111In-DTPA-adduct of Met into urine, 111In-DTPA-Met1-octreotide was synthesized and the renal handling of 111In-DTPA-Met was investigated using 111In-DTPA-L-Phe1-octreotide (Phe represents phenylalanine), which was reported previously, as a reference. Both 111In-DTPA-conjugated octreotide analogs were stable against 3-h incubation in murine serum at 37°C. Both 111In-DTPA-octreotide analogs also showed rapid clearance of the radioactivity from the blood and similar accumulation of the radioactivity in the kidney. No significant differences were observed in the renal radioactivity levels from 10 min to 24 h postinjection between the two. Metabolic studies indicated that 111In-DTPA-Met1-octreotide and 111In-DTPA-L-Phe1-octreotide generated 111In-DTPA-adducts of Met and Phe, respectively, as the final radiometabolites at similar rates. These findings suggested that the long residence times of the radioactivity in tissues after administration of 111In-DTPA-labeled peptides and polypeptides would be attributed to inherent characteristics of 111In-DTPA chelate.

KW - In-DTPA chelate

KW - In-DTPA-amino acid

KW - In-DTPA-peptide

KW - Renal radioactivity level

UR - http://www.scopus.com/inward/record.url?scp=0035005266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035005266&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(01)00207-4

DO - 10.1016/S0969-8051(01)00207-4

M3 - Article

VL - 28

SP - 459

EP - 468

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 4

ER -